Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?

Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?

Atherosclerosis is a chronic inflammatory disease of the arterial wall, characterized by the formation of plaques containing lipid, connective tissue and immune cells in the intima of large and medium-sized arteries. Over the past three decades, a substantial reduction in cardiovascular mortality ha...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Engelen, SE, Robinson, AJB, Zurke, Y-X, Monaco, C
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Springer Nature 2022

Míreanna comhchosúla

Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.
de réir: Full, L, et al.
Foilsithe / Cruthaithe: (2011)

Atherosclerosis and inflammation: therapeutic targets and ways of correction
de réir: A. A. Klimenko, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Atherosclerosis and inflammation: Current therapeutic strategies. A review
de réir: Marina Yu. Zubareva, et al.
Foilsithe / Cruthaithe: (2024-05-01)

CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
de réir: Lutgens, E, et al.
Foilsithe / Cruthaithe: (2023)

Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
de réir: Cole, J, et al.
Foilsithe / Cruthaithe: (2010)

The role of natural killer T cells in atherosclerosis
de réir: Engelen, SE
Foilsithe / Cruthaithe: (2022)

The Role of Inflammation in Atherosclerosis: A Comprehensive Review of Mechanisms and Therapeutic Targets
de réir: Omar Elsaka
Foilsithe / Cruthaithe: (2024-06-01)

Inflammation and immune responses in atherosclerosis.
de réir: Greaves, D, et al.
Foilsithe / Cruthaithe: (2002)

FAK Family Kinases: A Potential Therapeutic Target for Atherosclerosis
de réir: Guan X, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis.
de réir: Monaco, C, et al.
Foilsithe / Cruthaithe: (2004)

Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
de réir: Antonopoulos, A, et al.
Foilsithe / Cruthaithe: (2009)

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
de réir: Peng Kong, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Gene therapy targeting inflammation in atherosclerosis.
de réir: Van-Assche, T, et al.
Foilsithe / Cruthaithe: (2011)

Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice
de réir: Tuñón, J, et al.
Foilsithe / Cruthaithe: (2018)

Innate Immune Memory in Monocytes and Macrophages: The Potential Therapeutic Strategies for Atherosclerosis
de réir: Zhigang Guo, et al.
Foilsithe / Cruthaithe: (2022-12-01)

NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics
de réir: Na Lu, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
de réir: Zhiyue Wang, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Role and Therapeutic Targeting Strategies of Neutrophil Extracellular Traps in Inflammation
de réir: Li X, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
de réir: Lele Jing, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis
de réir: Antonio Cervadoro, et al.
Foilsithe / Cruthaithe: (2018-11-01)

Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.
de réir: Chan, J, et al.
Foilsithe / Cruthaithe: (2014)

MACROPHAGE ACTIVATION DURING CHRONIC INFLAMMATION IN ATHEROSCLEROSIS
de réir: Falck-Hansen, M, et al.
Foilsithe / Cruthaithe: (2012)

Shear-sensitive factors in therapeutic targets for atherosclerosis
de réir: ZHAO Chuan-rong, ZHOU Jing
Foilsithe / Cruthaithe: (2022-03-01)

Editorial: The molecular mechanisms and therapeutic targets of atherosclerosis
de réir: Roberta Gualtierotti, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Exploration and Validation of Immune and Therapeutic-Related Hub Genes in Aortic Valve Calcification and Carotid Atherosclerosis
de réir: Wei K, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Inflammation and Atherosclerosis
de réir: Klaus Ley
Foilsithe / Cruthaithe: (2021-05-01)

A single-cell genomic based investigation of immune cells in the aorta and adipose tissue during metabolic disease progression
de réir: Zurke, YX
Foilsithe / Cruthaithe: (2023)

How autophagy, a potential therapeutic target, regulates intestinal inflammation
de réir: Shuang-Lan Chen, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Moving from lipids to leukocytes: inflammation and immune cells in atherosclerosis
de réir: Maxim E. Annink, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Immune and Smooth Muscle Cells Interactions in Atherosclerosis: How to Target a Breaking Bad Dialogue?
de réir: Damien Ramel, et al.
Foilsithe / Cruthaithe: (2019-11-01)

Targeting fatty acid synthase reduces aortic atherosclerosis and inflammation
de réir: Rodrigo Meade, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Fatty Acid Synthase Targeting Reduces Aortic Atherosclerosis and Inflammation
de réir: Rodrigo Meade, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
de réir: Emily Punch, et al.
Foilsithe / Cruthaithe: (2022-02-01)

Natural products against inflammation and atherosclerosis: Targeting on gut microbiota
de réir: Bing Deng, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Lysosome Functions in Atherosclerosis: A Potential Therapeutic Target
de réir: Zhengchao Wang, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis
de réir: Tien K. Nguyen, et al.
Foilsithe / Cruthaithe: (2022-10-01)

MD-2 as a possible therapeutic target for atherosclerosis
de réir: Shuang Chen, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Innate immunity and monocyte-macrophage activation in atherosclerosis.
de réir: Shalhoub, J, et al.
Foilsithe / Cruthaithe: (2011)

INFECTIONS, INFLAMMATION AND ATHEROSCLEROSIS
de réir: O. V. Reshetnikov, et al.
Foilsithe / Cruthaithe: (2019-06-01)

Inflammation and autoimmunity in atherosclerosis
de réir: Stanislaw Surma, et al.
Foilsithe / Cruthaithe: (2022-02-01)